Spark Grants: Novel Technology Applications in Cancer Prevention and Early Detection
The Canadian Cancer Society, the CIHR Institute of Cancer Research, and Brain Canada Foundation have committed a total of up to $2.4M over one year to jointly fund Spark Grants at up to $150K each, focused on Novel Technology Applications in Cancer Prevention and Early Detection. The intent of this program is to “spark” new activity in the development and/or application of truly novel approaches to cancer prevention and early detection.
Registration deadline is August 28th, 2020. More information on this funding opportunity can be found at: https://www.cancer.ca/en/research/grants-and-awards/current-funding-opportunities/spark-grants/.
Spark Grants: Novel Technology Applications in Cancer Prevention and Early Detection
The Canadian Cancer Society, the CIHR Institute of Cancer Research, and Brain Canada Foundation have committed a total of up to $2.4M over one year to jointly fund Spark Grants at up to $150K each, focused on Novel Technology Applications in Cancer Prevention and Early Detection. The intent of this program is to “sp... Read More »
The Canadian Cancer Society, the CIHR Institute of Cancer Research, and Brain Canada Foundation have committed a total of up to $2.4M over one year to jointly fund Spark Grants at up to $150K each, focused on Novel Technology Applications in Cancer Prevention and Early Detection. The intent of this program is to “sp... Read More »
New Member to the CCRA Board
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »